Life
FDA Approves Leucovorin for Rare Brain Disorder, Rejects Autism Treatment Claims
The FDA has approved leucovorin for a rare brain disorder but has clarified that there is no evidence to support its use as a treatment for autism, countering previous assertions.
Editorial Staff
1 min read
The FDA has officially approved leucovorin for the treatment of a rare brain disorder, marking a significant regulatory decision.
However, the agency has also stated that there is no scientific evidence to support the use of leucovorin as a treatment for autism.
This clarification comes after earlier claims from top officials suggested potential benefits for children with autism, indicating a shift in the FDA's stance on the drug's applications.